Analysts expect Vaxart, Inc. to report revenue of 15.22 M for Q3 26, against a range of 14.10 M to 16.33 M. The most recent reported quarter, Q2 26, came in at 27.18 M, a 8.6% beat against the 25.03 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.93 M | 15.19 M | 20.88 M | 39.73 M | 72.41 M | 104.24 M | 39.23 M | 27.18 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 2.10 M | 21.22 M | 3.14 M | 2.24 M | 46.51 M | 80.05 M | 70.39 M | 27.41 M | 16.33 M | 15.21 M | 23.22 M | 16.65 M | 33.05 M | 33.61 M | 62.56 M | 68.97 M | ||||||||||
| Low Estimate | 1.96 M | 17.45 M | 2.89 M | 1.91 M | 38.18 M | 66.68 M | 63.95 M | 22.66 M | 14.10 M | 12.89 M | 20.23 M | 14.76 M | 30.65 M | 31.26 M | 54.53 M | 61.77 M | ||||||||||
| Consensus Estimate | 2.03 M | 19.34 M | 3.01 M | 2.08 M | 42.34 M | 73.37 M | 67.17 M | 25.03 M | 15.22 M | 14.05 M | 21.72 M | 15.71 M | 31.85 M | 32.43 M | 58.54 M | 65.37 M |
Analysts expect Vaxart, Inc. to report earnings per share of -0.16 for Q3 26, against a range of -0.17 to -0.15. The most recent reported quarter, Q2 26, came in at -0.06, a 50.0% beat against the -0.12 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.06 | -0.04 | -0.07 | -0.07 | -0.04 | -0.11 | 0.02 | -0.06 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.09 | -0.08 | -0.10 | -0.08 | -0.07 | -0.05 | 0.02 | -0.11 | -0.15 | 0.20 | -0.13 | -0.25 | -0.37 | -0.16 | -0.09 | -0.18 | ||||||||||
| Low Estimate | -0.09 | -0.10 | -0.10 | -0.10 | -0.07 | -0.05 | 0.02 | -0.13 | -0.17 | 0.16 | -0.15 | -0.27 | -0.45 | -0.18 | -0.11 | -0.22 | ||||||||||
| Consensus Estimate | -0.09 | -0.09 | -0.10 | -0.09 | -0.07 | -0.05 | 0.02 | -0.12 | -0.16 | 0.18 | -0.14 | -0.26 | -0.41 | -0.17 | -0.10 | -0.20 |
Pull Wall Street consensus for Vaxart, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VXRT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VXRT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VXRT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();